Stockreport

Cellectis: Cheap With Promising But Speculative Cancer Therapies [Seeking Alpha]

Cellectis S.A. - American Depositary Shares  (CLLS) 
Last cellectis s.a. - american depositary shares earnings: 3/4 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: cellectis.com/en/investors
PDF Myriam Alvarez 1.54K Follower s Follow Summary Cellectis S.A. leverages its UCART platform and TALEN gene-editing technology to develop innovative, off-the-shel [Read more]